Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00319904 · ClinicalTrials.gov registry record
The Partners Genetics Collaborative Study of Schizophrenia
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 451
- Enrollment target
NCT00319904: Completed study, sponsored by Massachusetts General Hospital.
NCT00319904 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 451 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00319904 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 451 participants
- Enrollment target
Study Summary
We will collect DNA from 500 rigorously diagnosed patients with schizophrenia to allow us in the future to examine phenotypic subtypes in relation to genetic variants. Phenotypes will include subgroups based on clinical symptoms, medication response, or other biological markers including neuroimaging or pharmacologic challenges.
Primary Outcome
We will collect DNA from 500 patients with schizophrenia to examine phenotypic subtypes in relation to genetic variants. Phenotypes will include subgroups based on clinical symptoms, medication response, or other biological markers including neuroimaging or pharmacologic challenges.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 451 participants |
| Start Date | 2001-03 |
| Est. Completion | 2017-10 |
What the finished NCT00319904 record still lists
NCT00319904 is an observational study that tracks outcomes without assigning an intervention. The registered 451 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00319904 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00319904 about?
NCT00319904 is a clinical study titled "The Partners Genetics Collaborative Study of Schizophrenia". We will collect DNA from 500 rigorously diagnosed patients with schizophrenia to allow us in the future to examine phenotypic subtypes in relation to genetic variants. Phenotypes will include subgroups based on clinical symptoms, medication response, or other biological markers including neuroimagin...
What is the current status of trial NCT00319904?
This trial is currently completed. The enrollment target is 451 participants. The study started on 2001-03. Estimated completion is 2017-10.
Who is sponsoring clinical trial NCT00319904?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05676255 · 452 participants · Phase 2
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
- NCT05703178 · 452 participants · Phase 3
Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia